1
|
Li YX, Chen YJ, Chang LJ, Hendryx M and
Luo JH: Clinical biomarkers and prognosis in Taiwanese patients
with Non-small cell lung cancer (NSCLC). J Cancer Ther. 3:412–423.
2012. View Article : Google Scholar
|
2
|
Hecht SS: Tobacco smoke carcinogens and
lung cancer. J Natl Cancer Inst. 91:1194–1210. 1999. View Article : Google Scholar : PubMed/NCBI
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhao ZQ, Tian W, Wang L, Wang H, Qin X,
Xing Q, Pang S and Yan B: Genetic and functional analysis of the
TBX3 gene promoter in indirect inguinal hernia. Gene. 554:101–104.
2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Takashima Y and Suzuki A: Regulation of
organogenesis and stem cell properties by T-box transcription
factors. Cell Mol Life Sci. 70:3929–3945. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chan YS, Göke J, Ng JH, Lu X, Gonzales KA,
Tan CP, Tng WQ, Hong ZZ, Lim YS and Ng HH: Induction of a human
pluripotent state with distinct regulatory circuitry that resembles
preimplantation epiblast. Cell Stem Cell. 13:663–675. 2013.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Wang HC, Meng QC, Shan ZZ, Yuan Z and
Huang XY: Overexpression of Tbx3 predicts poor prognosis of
patients with resectable pancreatic carcinoma. Asian Pac J Cancer
Prev. 16:1397–1401. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Peres J, Mowla S and Prince S: The T-box
transcription factor, Tbx3, is a key substrate of AKT3 in
melanomagenesis. Oncotarget. 6:1821–1833. 2014. View Article : Google Scholar
|
9
|
Du HF, Ou LP, Yang X, Song XD, Fan YR, Tan
B, Luo CL and Wu XH: A new PKCα/β/TBX3/E-cadherin pathway is
involved in PLCε-regulated invasion and migration in human bladder
cancer cells. Cell Signal. 26:580–593. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shan ZZ, Yan XB, Yan LL, Tian Y, Meng QC,
Qiu WW, Zhang Z and Jin ZM: Overexpression of Tbx3 is correlated
with epithelial-mesenchymal transition phenotype and predicts poor
prognosis of colorectal cancer. Am J Cancer Res. 5:344–353.
2015.PubMed/NCBI
|
11
|
Li J, Ballim D, Rodriguez M, Cui R, Goding
CR, Teng H and Prince S: The anti-proliferative function of the
TGF-β1 signaling pathway involves the repression of the oncogenic
Tbx2 by its homologue Tbx3. J Biol Chem. 289:35633–35643. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Washkowitz AJ, Gavrilov S, Begum S and
Papaioannou VE: Diverse functional networks of Tbx3 in development
and disease. Wiley Interdiscip Rev Syst Biol Med. 4:273–283. 2012.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Rattenbacher B, Beisang D, Wiesner DL,
Jeschke JC, von Hohenberg M, St Louis-Vlasova IA and Bohjanen PR:
Analysis of CUGBP1 targets identifies GU-repeat sequences that
mediate rapid mRNA decay. Mol Cell Biol. 30:3970–3980. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Peres J, Davis E, Mowla S, Bennett DC, Li
JA, Wansleben S and Prince S: The highly homologous T-box
transcription factors, Tbx2 and Tbx3, have distinct roles in the
oncogenic process. Genes Cancer. 1:272–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wensing LA and Campos AH: TBX3, a
downstream target of TGF-β1, inhibits mesangial cell apoptosis. Exp
Cell Res. 328:340–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Gao C, Yu Z, Liu S, Xin H and Li X:
Overexpression of CUGBP1 is associated with the progression of
non-small cell lung cancer. Tumor Biol. 36:4583–4589. 2015.
View Article : Google Scholar
|
18
|
Liu Y, Gao WM, Siegfried JM, Weissfeld JL,
Luketich JD and Keohavong P: Promoter methylation of RASSFIA and
DAPK and mutations of K-ras, p53, and EGFR in lung tumors from
smokers and never-smokers. BMC cancer. 7:742007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhao S, Qiu ZX, Zhang L and Li W:
Prognostic values of ERK1/2 and p-ERK1/2 expressions for poor
survival in non-small cell lung cancer. Tumor Biol. 36:4143–4150.
2015. View Article : Google Scholar
|
20
|
Ohgami A, Mitsudomi T, Sugio K, Tsuda T,
Oyama T, Nishida K, Osaki T and Yasumoto K: Micrometastatic tumor
cells in the bone marrow of patients with non-small cell lung
cancer. Ann Thorac Surg. 64:363–367. 1997. View Article : Google Scholar : PubMed/NCBI
|
21
|
Pavese J, Odgen IM and Bergan RC: An
orthotopic murine model of human prostate cancer metastasis. J Vis
Exp. e50873:2013.
|